| Samuel Klandrud, PHARMD | |
|
2519 Kettering St, Janesville, WI 53546-1015 | |
| (608) 754-0007 | |
| Not Available |
| Full Name | Samuel Klandrud |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 2519 Kettering St, Janesville, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043959810 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 21272-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Samuel Klandrud, PHARMD 2930 Smith Dr, Brookfield, WI 53005-3573 Ph: () - | Samuel Klandrud, PHARMD 2519 Kettering St, Janesville, WI 53546-1015 Ph: (608) 754-0007 |
News Archive
ProAssurance Corporation today highlighted recent rating actions by A.M. Best, affirming the "A" Excellent ratings assigned to the ProAssurance Group and upgrading The PICA Group and The Podiatry Insurance Company of America (PICA) to "A" (Excellent) and ProAssurance National Casualty to "A-" (Excellent). The ratings outlook for each is Stable. Further, Best affirmed the "A-" (Excellent) Ratings of ProAssurance Wisconsin and PACO Assurance Company, a subsidiary of PICA.
In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch.
FDA has issued a revised guidance to help drugmakers determine how they should report postapproval manufacturing changes to new drug applications (NDAs) or abbreviated new drug applications (ANDAs).
Today's headlines include a report about an uptick in VA referrals to private physicians. Kaiser Health News staff writer Julie Appleby reports: "Some hospitals in New York, Florida and Wisconsin are exploring ways to help individuals and families pay their share of the costs of government-subsidized policies purchased though the health law's marketplaces – at least partly to guarantee the hospitals get paid when the consumers seek care.
BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase 2 trial for BL-8040, for the treatment of acute myeloid leukemia.
› Verified 4 days ago
Pauline R Cass, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6000 | |
Ghee Syn Ong, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3800 Deerfield Drive, Janesville, WI 53545 Phone: 608-754-3030 | |
Jamie L Stokstad, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 E Us Highway 14, Janesville, WI 53545 Phone: 608-754-7450 Fax: 608-754-1777 | |
Alicia Ann Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1717 Milton Ave, Janesville, WI 53545 Phone: 608-754-2278 | |
Stephanie Moran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2519 Kettering St, Janesville, WI 53546 Phone: 608-754-0007 | |
Erin Leigh Smerchek, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21 S Jackson St, Janesville, WI 53548 Phone: 608-752-7859 Fax: 608-752-6806 |